Ficolin-2 triggers antitumor effect by activating macrophages and CD8+ T cells

Quanquan Ding1, Yanying Shen1, Dongqing Li2

  • 1State Key Laboratory of Virology and Medical Research Institute, Hubei Province Key Laboratory of Allergy and Immunology and Department of Immunology, Wuhan University School of Basic Medical Sciences, Wuhan 430071, PR China.

Insights

Serum ficolin-2 levels are lower in cancer patients. Supplementing ficolin-2 inhibits tumor growth by activating immune cells like macrophages and CD8+ T cells, suggesting a new cancer therapy.

Area of Science:

  • Immunology
  • Oncology
  • Biochemistry

Background:

  • Ficolin-2 is a serum complement lectin.
  • Lower serum ficolin-2 concentrations are observed in patients with multiple tumors compared to healthy individuals.

Purpose of the Study:

  • To investigate the role of ficolin-2 in tumor growth.
  • To explore ficolin-2 as a potential therapeutic agent for cancer.

Main Methods:

  • Administration of exogenous ficolin-2 or ficolin-A in murine tumor models.
  • Analysis of immune cell responses (macrophages, dendritic cells, CD8+ T cells, CD4+ T cells).
  • Assessment of tumor cell growth in wild-type and Ficolin-A knockout mice.
  • Investigation of ficolin-2 binding to Toll-like receptor 4 (TLR4).

Main Results:

  • Single administration of ficolin-2 or ficolin-A significantly inhibited tumor cell growth in murine models.
  • Ficolin-A knockout mice showed increased tumor cell growth.
  • Ficolin-2 activated macrophages, promoted M1 polarization, and enhanced CD8+ T cell proliferation and cytotoxicity.
  • Ficolin-2 binds to TLR4 on macrophages and dendritic cells, improving their antigen-presenting capabilities.

Conclusions:

  • Ficolin-2 exhibits potent antitumor effects by modulating the immune system.
  • Ficolin-2 enhances innate and adaptive immune responses against tumors.
  • Ficolin-2 represents a promising therapeutic strategy for cancer by leveraging immune-mediated antitumor effects.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.8K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.6K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.2K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.0K